| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $79.2M | +43.3% |
| SG&A Expense | $74.4M | +53.9% |
| Operating Income | -$153.7M | -48.2% |
| Interest Expense | $360K | -95.6% |
| Pre-tax Income | -$103.2M | +16.9% |
| Income Tax | $0 | — |
| Net Income | -$103.2M | +16.9% |
| EPS (Basic) | -$4.49 | +66.5% |
| EPS (Diluted) | -$4.49 | +66.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $157.6M | -40.4% |
| Current Assets | $165.6M | -40.3% |
| Total Assets | $214.7M | -26.2% |
| Current Liabilities | $8.7M | +44.5% |
| Long-term Debt | $1.8M | +65.7% |
| Total Liabilities | $29.8M | -47.2% |
| Stockholders' Equity | $185.0M | -21.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.4M | -50.1% |
| Capital Expenditures | $10.4M | +210.6% |
| Investing Cash Flow | -$10.0M | -120.2% |
| Financing Cash Flow | $902K | -99.7% |
| Free Cash Flow | -$107.8M | -58.0% |